验证EncephalAppStroop测试用于诊断罗马尼亚人口中最小肝脏脑病的诊断
Ioan Cristian Lupescu1, Speranța Maria Iacob2, Corina Pietrăreanu2
1Neurology Department, Fundeni Clinical Institute, Bucharest; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. cristian.lupescu@drd.umfcd.ro.
Journal of gastrointestinal and liver diseases : JGLD
|September 10, 2024
概括
EncephalApp Stroop 测试可以有效地诊断肝硬化患者的最小肝脑病变 (MHE). 绩效与年龄和肝病严重程度有关,但与教育或疾病持续时间无关.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 神经学 神经学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 最小肝脑病变 (MHE) 是肝脑病变的最早期阶段,由于其微妙的表现,经常被忽视.
- MHE显著损害生活质量,工作表现,并导致肝硬化患者过早退休.
- 早期诊断MHE对于肝硬化患者的及时干预和管理至关重要.
研究的目的:
- 评估EncephalApp Stroop测试作为肝硬化患者中MHE的诊断工具.
- 确定Stroop测试性能与临床/实验室参数之间的相关性,包括年龄,教育,肝病严重程度 (MELD,Child-Pugh) 和并发症.
主要方法:
- 一项涉及100名成年肝硬化患者和45名健康对照者的横截面研究.
- 患者和对照组接受了MHE评估的EncephalApp Stroop测试.
- 数据分析探讨了Stroop测试结果与各种临床,人口和实验室因素之间的相关性.
主要成果:
- 与健康对照组相比,肝硬化患者的Stroop测试表现明显较差 (p<0.0001).
- 斯特鲁普测试结果与MELD (R=0.28,p=0.005) 和Child-Pugh分数 (R=0.2,p=0.04) 呈正相关性,表明疾病严重程度增加的表现较差.
- 较差的表现与老年,酒精性肝病,糖尿病,高血糖,贫血和低血症有关. 教育和疾病持续时间没有显著影响.
结论:
- EncephalApp Stroop Test是一种快速而简单的方法,用于在医院环境中诊断MHE.
- 测试性能主要受患者年龄和肝病严重程度的影响.
- 贫血,低血和高血糖等因素也会影响Stroop测试结果,强调MHE呈现的多因素性质.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


